| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 9 | 0.543 | 0.615 | 4.8E-19 |
|
phenotype | 0.320 | None | 1.000 | 2 | 0 | 2011 | 2018 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 1.000 | 11 | 3 | 2000 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 2006 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.060 | None | 1.000 | 6 | 1 | 2006 | 2019 | ||||||||
|
purinergic receptor P2X 3 | 0.565 | 0.769 | 1.0E-06 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2003 | 2018 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2018 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.040 | None | 1.000 | 4 | 4 | 2010 | 2019 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
phenotype | 0.030 | None | 1.000 | 3 | 1 | 2018 | 2019 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2019 | 2019 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily M member 8 | 0.553 | 0.808 | 4.6E-29 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
POTE ankyrin domain family member M | 0.541 | 0.769 | 3.2E-04 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
glutamate metabotropic receptor 5 | 0.525 | 0.846 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
purinergic receptor P2X 2 | 0.585 | 0.769 | 9.7E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
dual specificity phosphatase 2 | 0.558 | 0.769 | 4.5E-05 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
free fatty acid receptor 1 | 0.619 | 0.577 | 7.6E-04 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
purinergic receptor P2Y1 | 0.551 | 0.769 | 0.52 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
purinergic receptor P2X 5 | 0.548 | 0.769 | 2.9E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
purinergic receptor P2X 4 | 0.547 | 0.808 | 5.0E-12 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
purinergic receptor P2X 1 | 0.584 | 0.808 | 6.8E-11 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 |